Travis
Member
- Joined
- Jul 14, 2016
- Messages
- 3,189
A few molecules, certainly, but not enough to be detected."Moderate affinity" is not "zero affinity". Small effect does not equal zero effect. Anything that absorbs into your skin will, to some degree, enter the circulation,
This wasn't statistics, this was high‐performance liquid chromatography.⁽¹⁾...regardless of whether researchers decide it meets some level of statistical significance or not.
Five percent spironolactone mixed with 'purified water 66.35%, propylene glycol 12%, vaseline oil 8%, cetostearyl alcohol 4.5%, cetomacrogol 1000 4%, adjuvants 0.65%.' had been applied over a body area comprising 55% of the total leading to undetectable levels. If applied to the head—or less than 55% of the total body area—you would expect even less to be absorbed (or negative undetectable, if there was such a thing.)
They also say this:
'Caminos-Torres et al. (6) revealed that no change occurred in the average concentration of pT [plasma testosterone] after a four week treatment with high doses of spironolactone (400 mg/ day) in normal men while the free fraction of testosterone increased significantly, probably due to the displacement of testosterone from plasma binding proteins as confirmed in vitro. In a five day study, Stripp et al. (7) did not find any change in pT concentration, but showed a significant rise in plasma 17a-OH-P which persisted throughout the study. Other authors, like Pentikainen et al. (8) observed a slight decrease of pT after moderate treatment over a short period of time.' ―Rey⁽¹⁾
Certainly, eplerenone would be a better choice for most because it has essentially no androgenic effect. I cannot think of a reason to even take an antiandrogen—like finasteride—besides for those with prostate enlargement. But topically, I certainly can see no harm in using spironolactone—a cheaper, and more available drug than eplerenone (spironolactone is synthesized in relatively great amounts oversees).
And the reason why blocking the mineralcorticoid receptor works is that the scalp is characterized by a prostaglandin D synthase gradient⁽²⁾⁽³⁾ and the mineralocorticoid receptor is responsible for transcribing this enzyme—as determined by quantitative PCR.⁽⁴⁾ The prostaglandin D synthase gene also has been shown to have a mineralocorticoid response element.⁽⁵⁾
'PTGDS mRNA level was also increased in MAF from adipo-MROE mice when compared with MAF from control-MR littermates (relative PTGDS mRNA level: control-MR, 1.0±0.1 and adipo-MROE, 2.4±0.4) suggesting that MR [mineralcorticoid receptor] might directly control PTGDS transcription in adipocytes. Importantly, 10−8 mol/L aldo[sterone] increased PTGDS mRNA level in adipocytes derived from adipo-MROE SAT (Figure 5B). This increase was abolished by coincubation with 10−6 mol/L MR antagonist spironolactone (Figure 5B).' ―Urbanet
I do routinely point out that linoleic acid is the only precursor to prostaglandin D₂. Prostaglandin D₃ can be made by eicosapentaenoic acid, but this hasn't been shown to cause hair loss. Besides avoiding linoleic acid for hair loss, this can also perhaps avoid cancer in some people. Prostaglandin E₂ upregualtes ornithine decarboxylase and increases proliferation. I have tried to find epidemiological evidence for linoleic acid consumption and hair loss, but I haven't seen any. Perhaps the best one can do is look at the observations of Ian Prior.Why would you not address the underlying deficiencies and toxicities causing the adjusted homeostasis that's leading to the pathology? Wouldn't a much more logical resolution include managing lifestyle rather than an eternity of rubbing sorta-kinda-maybe-specific chemicals into your scalp? If serotonin, parathyroid, prolactin, prostaglandins, etc. are at the heart of hair loss, wouldn't it stand to reason there is more to rectified in the individual than just the "superficial" state of hair loss? Why would we not seek to heal the individual in totality, rather than patch symptoms? Even a cursory review of the literature demonstrates age-adjusted hair loss is associated with countless other pathologies.
I haven't seen any evidence showing that serotonin, parathyroid, or prolactin were etioligical factors.
Aldosterone can be modified through sodium intake, and aldosterone has been shown a factor in hair loss.⁽⁶⁾ Just like cortisol, aldosterone binds the mineralocorticoid receptor. Cortisol can be modified by diet, but I would feel ashamed to recommend yoga: some people really need their adrenals, and not everybody has the luxury of having a stress‐free environment or occupation.
'Patients with AGA showed significantly higher systolic blood pressure values and aldosterone levels (197±35 vs. 133±71 pg mL) vs. controls.' ―Arias‐Santiago⁽⁶⁾
Spironolactone can antagonize the mineralocorticoid receptor and would be expected to limit the induction of prostaglandin D synthase. Lowering aldosterone and/or cortisol by any mechanism (i.e. 11β-HSD₁ inhibitor, stress, or sodium), would be expected to do likewise.
The long-observed negative effect of cortisol on hair growth does not contradict the findings of Louis Garza, but only adds to the weight of evidence directly implicating prostaglandin D₂/J₂.
[1] Rey, F. O. "Lack of endocrine systemic side effects after topical application of spironolactone in man." Journal of endocrinological investigation (1988)
[2] Larson, Allison R. "A prostaglandin d‐synthase‐positive mast cell gradient characterizes scalp patterning." Journal of cutaneous pathology (2014)
[3] Garza, Luis A. "Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia." Science translational medicine (2012)
[4] Urbanet, Riccardo. "Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase." Hypertension (2015)
[5] Wilhelm, Dagmar. "SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development." Journal of Biological Chemistry (2007)
[6] Arias‐Santiago, S. "Elevated aldosterone levels in patients with androgenetic alopecia." British Journal of Dermatology (2009)
[2] Larson, Allison R. "A prostaglandin d‐synthase‐positive mast cell gradient characterizes scalp patterning." Journal of cutaneous pathology (2014)
[3] Garza, Luis A. "Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia." Science translational medicine (2012)
[4] Urbanet, Riccardo. "Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase." Hypertension (2015)
[5] Wilhelm, Dagmar. "SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development." Journal of Biological Chemistry (2007)
[6] Arias‐Santiago, S. "Elevated aldosterone levels in patients with androgenetic alopecia." British Journal of Dermatology (2009)
Last edited: